Figure 7. Expression of CSPG4 in BLCA and its prognostic validation in patients with BLCA. (A) Immunohistochemical validation of CSPG4 expression in bladder tumors and adjacent normal tissues. (B) CSPG4 expression in bladder tumors and paired normal tissues. (C) CSPG4 expression in bladder tumors and unpaired normal tissues. (D) Prognostic analysis of CSPG4 expression in patients with BLCA. (E) Analysis of the survival and death rate in patients with BLCA exhibiting high and low CSPG4 expression. (F) Impact of CSPG4 expression on survival in patients with BLCA. (G) Predictive analysis of the survival of patients with BLCA in the next one, three, and five years based on CSPG4 expression. (H) Nomogram based on CSPG4 expression for the prognosis of patients with BLCA in the next one, three, and five years.